The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes
about
HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.The prevention of type 2 diabetes.The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention programRegression from pre-diabetes to normal glucose regulation in the diabetes prevention program.Parents as agents of change (PAC) in pediatric weight management: the protocol for the PAC randomized clinical trial.Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.Background and recruitment data for the U.S. Diabetes Prevention Program.Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsEvaluating surrogate marker information using censored data.Changing illness perceptions in patients with poorly controlled type 2 diabetes, a randomised controlled trial of a family-based intervention: protocol and pilot study.A smartphone-supported weight loss program: design of the ENGAGED randomized controlled trial.Smartphone applications to support weight loss: current perspectivesUse of the emergency department for less-urgent care among type 2 diabetics under a disease management program.The influence of rare genetic variation in SLC30A8 on diabetes incidence and β-cell function.Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherenceCommunity-based randomized controlled trial of diabetes prevention study for high-risk individuals of type 2 diabetes: lifestyle intervention using web-based systemParticipatory research maximises community and lay involvement. North American Primary Care Research GroupThe cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study.A cardiovascular risk reduction program for American Indians with metabolic syndrome: the Balance StudyConceptual basis and clinical rationale for the development of a multidisciplinary weight management centerPlasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.Changes in diet quality in a randomized weight loss trial in breast cancer survivors: the lifestyle, exercise, and nutrition (LEAN) study.Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.Reach and effectiveness of a weight loss intervention in patients with prediabetes in Colorado.Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007.The Diabetes Prevention Program (DPP): description of lifestyle interventionCirculating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.Impact of weight loss on physical function with changes in strength, muscle mass, and muscle fat infiltration in overweight to moderately obese older adults: a randomized clinical trialImpact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose toleranceDepression symptoms and antidepressant medicine use in Diabetes Prevention Program participants.Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program.Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention programRole of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention ProgramEffects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.Healthy Living Partnerships to Prevent Diabetes: recruitment and baseline characteristicsLipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program
P2860
Q27335063-1EA6B9C6-018D-413C-A58D-4E2A50F116E3Q30484253-3C53B063-7FDF-4D03-AEC4-955C19754DAEQ30486119-85B40542-4C09-4785-8781-965644E389CFQ30489774-8A1FC9DB-038D-4EA6-8E95-4EC4B2FBB99BQ30525604-AA392839-2F68-40EA-A541-D1DEEB26AE55Q30533186-5CC91A9C-2643-47A6-96E1-55E26FC1650EQ30537406-61E76D44-782A-4E8D-B57C-D696D5F9DF34Q30597884-9314AF23-2E85-4817-B9BF-5F5735BF5C66Q30708887-630F7348-5A76-4880-86D2-4CC8B76C9E7CQ31154746-EBF4DF48-BD14-4B17-BC81-52CA2D55E597Q33289137-BA3E5138-B50E-4BE2-8FF0-443A33F7C66DQ33439216-D5EF3C53-6E17-4F68-B8CE-4C641137C8AEQ33444584-C4C7E2FC-361C-48A2-8F43-8AD4662810DFQ33517484-88F85C64-C5B2-401B-8D5D-F158603AD1A9Q33568942-FE8D37C3-436D-4B1C-87B2-CF77F91B4AC7Q33589814-A4D0304D-0504-4F75-B1E4-6AA76B4411D2Q33644745-B63D75F4-193D-4F45-B3CD-51AD13446D1FQ33733294-0CC3EABE-C0B3-494D-BF0D-151AA06E1FADQ33801995-E45B892C-3813-4C4E-8799-9BD6A7EDB4A8Q33861064-7E8ADF12-3016-4731-94AE-DA78E76679E4Q33873335-422C0CA4-14C9-444C-8C3A-5EA2AD91C7ADQ33881452-5FF1276B-06B8-478D-85EA-81113EB3ADD4Q33915017-2A3A7A11-199D-4023-AA8F-DAD9833F4932Q34073458-7A42EEB2-D224-4F96-8B6F-F4B9EDCC2DFAQ34123465-22E1B6F7-F97A-4B6A-A3A7-48A1B8438B71Q34123506-8C6C5776-3845-4F38-8040-7E1ACD91D13CQ34130215-D04D3B45-5FCF-4A83-A391-12BCB2767BEDQ34153637-5211C432-6DF8-4917-A2E9-0D49A331729EQ34189514-B5B8FA5B-B6A2-4A4D-8F99-78CA0AEEF340Q34195798-11EC701D-82DF-462E-BE5C-98A5D3CF084EQ34225645-B8494F96-C315-4019-A056-C2E27AA22A05Q34225662-F16109E8-9655-4131-975E-2E0CE26D0A4DQ34225672-453E954F-A581-478B-B110-FE557E095DCDQ34312885-48D82F3D-0FCE-41C5-9765-683195CCAA96Q34335544-942CF0A8-DF54-4714-BA9B-CDA82E2F9AA1Q34335548-18981868-4C57-4BA5-B4AC-4469B39C6D70Q34404405-277A524A-4BE2-4E4B-8109-0D5C11B75F42Q34415887-03599EAC-5485-4433-AF30-511B28F0E34EQ34423911-BEE3248D-887D-47EC-A239-56483ED3511CQ34457386-AE94B571-A350-44C0-A941-593725379FDB
P2860
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes
description
im April 1999 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована у квітні 1999
@uk
name
The Diabetes Prevention Progra ...... prevention of type 2 diabetes
@en
type
label
The Diabetes Prevention Progra ...... prevention of type 2 diabetes
@en
prefLabel
The Diabetes Prevention Progra ...... prevention of type 2 diabetes
@en
P1433
P1476
The Diabetes Prevention Progra ...... prevention of type 2 diabetes
@en
P304
P407
P577
1999-04-01T00:00:00Z